Hostname: page-component-76d6cb85b7-5qg8f Total loading time: 0 Render date: 2026-07-25T04:58:41.746Z Has data issue: false hasContentIssue false
  • English
  • Français

CDC consultations related to ophthalmic practices and settings, January 2016–December 2023

Published online by Cambridge University Press:  27 August 2024

Kevin B. Spicer Open the ORCID record for Kevin B. Spicer [Opens in a new window] ,
Joseph F. Perz Open the ORCID record for Joseph F. Perz [Opens in a new window]  and
Kiran M. Perkins
Kevin B. Spicer*
Affiliation:
Prevention and Response Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Joseph F. Perz
Affiliation:
Prevention and Response Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Kiran M. Perkins
Affiliation:
Prevention and Response Branch, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
*
Corresponding author: Kevin B. Spicer; Email: spicecat47@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Consultations with the Centers for Disease Control and Prevention’s Division of Healthcare Quality Promotion revealed patient harms associated with ophthalmic care. Adherence to core infection prevention and control principles, tailored guidance for ophthalmic settings, and compliance with manufacturing and compounding standards could decrease adverse events and patient exposures to contaminated products.

Information

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 45 , Issue 10 , October 2024 , pp. 1230 - 1233
Check for updates
Creative Commons
To the extent this is a work of the US Government, it is not subject to copyright protection within the United States. To the extent this work is subject to copyright outside of the United States, such copyright shall be assigned to The Society for Healthcare Epidemiology of America and licensed to the Publisher. Outside of the United States, the US Government retains a paid-up, nonexclusive, irrevocable worldwide license to reproduce, prepare derivative works, distribute copies to the public and display publicly the Contribution, and to permit others to do so. Published by Cambridge University Press on behalf of The Society for Healthcare.
Copyright
© The Society for Healthcare Epidemiology of America, 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

A portion of this work was presented at SHEA Spring 2023, Abstract 121 (oral), Seattle, WA, USA, April 2023.

References

King, D, Johnson, B, Miller, D, et al. Adenovirus-associated epidemic keratoconjunctivitis outbreaks—four states, 2008–2010. MMWR Morb Mortal Wkly Rep 2013;62:637–641 Google Scholar
Muller, MP, Siddiqui, N, Ivancic, R, Wong, D. Adenovirus-related epidemic keratoconjunctivitis outbreak at a hospital-affiliated ophthalmology clinic. Am J Infect Control 2018;46:581–583 CrossRefGoogle Scholar
Mikosz, CA, Smith, RM, Kim, M, et al. Fungal endophthalmitis associated with compounded products. Emerg Infect Dis 2014;20:248–256 CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Health Alert Network. Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears. Available from: Health Alert Network (HAN)—00485 | Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears (cdc.gov). Accessed February 16, 2024.Google Scholar
Edens, C, Liebich, L, Laufer Halpin, A, et al. Notes from the Field: Mycobacterium chelonae eye infections associated with humidifier use in an outpatient LASIK clinic—Ohio, 2015. MMWR Morb Mortal Wkly Rep 2015;64:1177 CrossRefGoogle Scholar
Sen, S, Lalitha, P, Mishra, C, et al. Post-cataract surgery fungal endophthalmitis: management outcomes and prognostic factors. Ocul Immunol Inflamm 2021;29:1530–1536 CrossRefGoogle ScholarPubMed
Braun, BI, Chitavi, SO, Perkins, KM, et al. Referrals of infection control breaches to public health authorities: ambulatory care settings experience, 2017. Jt Comm J Qual Patient Saf 2020;46:531–541 Google ScholarPubMed
Centers for Disease Control and Prevention. CDC’s core infection prevention and control practices for safe healthcare delivery in all settings. Available from: CDC’s Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings | Infection Control | CDC. Accessed February 16, 2024Google Scholar
AAO Quality of Care Secretariat. Infection prevention in eye care services and operating areas and operating rooms—2012. American Academy of Ophthalmology. Available from: Infection Prevention in Eye Care Services and Operating Areas and Operating Rooms - 2012 - American Academy of Ophthalmology (aao.org). Accessed February 16, 2024Google Scholar
USP. Pharmaceutical compounding—sterile preparations. Available from: USP General Chapter 797. Accessed February 16, 2024Google Scholar